Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
90.29
-0.52 (-0.57%)
Aug 17, 2026, 9:31 AM EDT - Market open

Haemonetics Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Cash & Equivalents
223.38245.44306.76178.8284.47259.5
Trading Asset Securities
1.130.821.311.671.11-
Cash & Short-Term Investments
224.52246.26308.07180.47285.58259.5
Cash Growth
-23.61%-20.06%70.70%-36.80%10.05%34.94%
Receivables
216.07216.86202.66206.56179.14159.38
Inventory
306.74306.37365.14317.2259.38293.03
Prepaid Expenses
62.2363.8258.8363.1643.9240.9
Other Current Assets
1.281.580.281.511.73.23
Total Current Assets
810.83834.88934.98768.9769.72756.03
Property, Plant & Equipment
303.78345.38331.54366.63364.3311.23
Long-Term Investments
26.190.951.020.06--
Goodwill
656.88656.37604.27565.08466.23467.29
Other Intangible Assets
434.51510.06499.74429.02275.77310.26
Long-Term Deferred Tax Assets
9.439.527.87.745.244.47
Other Long-Term Assets
123.7738.7871.5958.1653.5610.46
Total Assets
2,3652,3962,4512,1961,9351,860

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Accounts Payable
56.3451.066773.3663.9358.37
Accrued Expenses
38.1568.1959.4280.7164.4848.54
Current Portion of Long-Term Debt
4.965.02303.5610.2311.78215.96
Current Portion of Leases
-9.248.118.137.167.2
Current Unearned Revenue
48.642.3143.3531.2430.2126.81
Other Current Liabilities
115.2106.7896.6896.7174.2685.39
Total Current Liabilities
263.24282.6578.11300.38251.82442.27
Long-Term Debt
1,1691,220921.23797.56755.91559.44
Long-Term Leases
-40.950.4557.9655.955.7
Long-Term Deferred Tax Liabilities
38.6938.0562.5862.6436.228.73
Other Long-Term Liabilities
57.1718.517.7417.0817.0124.17
Total Liabilities
1,5281,6001,6301,2361,1171,110

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Common Stock
0.460.450.480.510.50.51
Additional Paid-In Capital
566.76554.14523.26634.63594.71572.48
Retained Earnings
311.52279.34352.17360.46253.17202.39
Comprehensive Income & Other
-41.63-37.61-55.08-35.63-30.38-25.95
Shareholders' Equity
837.1796.32820.84959.96818749.42
Total Liabilities & Equity
2,3652,3962,4512,1961,9351,860

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Total Debt
1,1741,2751,283873.88830.76838.3
Net Cash (Debt)
-949.64-1,028-975.28-693.41-545.18-578.81
Net Cash Growth
------
Net Cash Per Share
-20.34-21.72-19.22-13.49-10.60-11.27
Filing Date Shares Outstanding
45.545.4548.0450.8450.5451.28
Total Common Shares Outstanding
45.4745.2548.2250.7950.4551.12
Working Capital
547.6552.28356.86468.52517.91313.77
Book Value Per Share
18.4117.6017.0218.9016.2114.66
Tangible Book Value
-254.3-370.1-283.18-34.1476-28.12
Tangible Book Value Per Share
-5.59-8.18-5.87-0.671.51-0.55
Land
2.322.251.994.135.365.17
Buildings
109.73109.79105.08124.34127.63104.36
Machinery
709699.84707.9791.02781.86706.01
Construction In Progress
33.2229.9422.2339.6929.3753.61
SEC Filings: 10-K · 10-Q